Gonadotropin Releasing Hormone Antagonist Stocks List
Related ETFs - A few ETFs which own one or more of the above listed Gonadotropin Releasing Hormone Antagonist stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PBE | B | PowerShares Dynamic Biotech & Genome | 5.25 | |
IBRN | D | iShares Neuroscience and Healthcare ETF | 4.8 | |
MNTL | C | Tema Neuroscience and Mental Health ETF | 4.58 | |
FBT | B | First Trust Amex Biotech Index Fund | 3.33 | |
JSMD | D | Janus Small/Mid Cap Growth Alpha ETF | 3.14 |
Compare ETFs
Related Industries:
Biotechnology
- Gonadotropin Releasing Hormone Antagonist
Gonadotropin Releasing Hormone Antagonist (GnRH Antagonist) is a type of medication used to treat certain reproductive health conditions, such as endometriosis, uterine fibroids, and precocious puberty. It works by blocking the action of gonadotropin-releasing hormone (GnRH), a hormone that stimulates the release of other hormones involved in the reproductive cycle. By blocking GnRH, GnRH Antagonist can help reduce the symptoms of these conditions.
Recent Comments
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
- ZealousTrout235 on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
- TraderMike on Market Recap for Tuesday, May 21, 2024
- CharmingMole371 on Market Recap for Tuesday, May 21, 2024
- TraderMike on IZM
From the Blog
Featured Articles